The identified biomarkers were compared with established diagnostic markers for PE, such as sFlt-1 and PlGF. The mechanism of sFlt-1 involves inhibiting normal angiogenesis, leading to placental dysfunction and symptoms like hypertension, while PlGF levels typically decrease in PE patients (41). The gene discussed is PGF; the disease is hypertensive disorder.